Skip to main content

Aeluma Names Brendan Moran Vice President of Engineering

Key Appointment to Drive Product Development and Commercialization Across Growing Markets

GOLETA, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today it has appointed Brendan Moran, Ph.D. as its Vice President of Engineering. Dr. Moran will drive the commercialization and manufacturing readiness of Aeluma’s compound semiconductor products.

Dr. Moran joins Aeluma following a distinguished 18-year career at Lumileds, where he most recently served as Senior Director of R&D, and previously as Senior Director of Product Development. During his tenure at Lumileds, Dr. Moran managed the product strategy and full-cycle development for a global mobile flash portfolio that generated more than $300 million in annual revenue and captured eight consecutive flagship design-ins for a high-profile customer. He led a global product development organization of more than 20 engineers and program managers and orchestrated the release of more than 25 innovative products to high-volume manufacturing that totaled more than four billion units. Dr. Moran also served as Principal Engineer at Allux Medical earlier in his career, developing a wearable LED phototherapy platform and taking it through clinical trials and 510(k) FDA clearance.

At Aeluma, Dr. Moran will lead the engineering organization as the company transitions its promising technologies into market-ready products for AI infrastructure, mobile and consumer electronics, defense and aerospace, and quantum.

“We are excited to welcome Brendan to the Aeluma team,” said Jonathan Klamkin, Ph.D., President and CEO. “His experience with scaling semiconductor photonics for consumer markets comes at a pivotal time with commercial traction growing across our target markets. Brendan’s proven leadership will help accelerate our transition to commercial-scale manufacturing and broad market product introduction.”

Dr. Moran commented, “The versatility of Aeluma’s scalable heterogeneous integration platform presents a massive opportunity to meet the current high customer demand for compound semiconductor devices in the communications and sensing markets. At this exciting time for Aeluma, I am very pleased to join and help drive the next stage of growth.”

Dr. Moran holds a Ph.D. in Materials from the University of California Santa Barbara. He will report directly to President and CEO Dr. Jonathan Klamkin.

About Aeluma

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:
Aeluma, Inc.
(805) 351-2707
info@aeluma.com

Investor Contact:
Financial Profiles, Inc.
Moira Conlon and Alex Villalta
(310) 622-8227
ir@aeluma.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.